Literature DB >> 22582264

Use of SPME-HS-GC-MS for the analysis of herbal products containing synthetic cannabinoids.

Anderson O Cox1, Richard C Daw, Michele D Mason, Megan Grabenauer, Poonam G Pande, Kenneth H Davis, Jenny L Wiley, Peter R Stout, Brian F Thomas, John W Huffman.   

Abstract

The increasing prevalence and use of herbal mixtures containing synthetic cannabinoids presents a growing public health concern and legal challenge for society. In contrast to the plant-derived cannabinoids in medical marijuana and other cannabinoid-based therapeutics, the commonly encountered synthetic cannabinoids in these mendaciously labeled products constitute a structurally diverse set of compounds of relatively unknown pharmacology and toxicology. Indeed, the use of these substances has been associated with an alarming number of hospitalizations and emergency room visits. Moreover, there are already several hundred known cannabinoid agonist compounds that could potentially be used for illicit purposes, posing an additional challenge for public health professionals and law enforcement efforts, which often require the detection and identification of the active ingredients for effective treatment or prosecution. A solid-phase microextraction headspace gas chromatography-mass spectrometry method is shown here to allow for rapid and reliable detection and structural identification of many of the synthetic cannabinoid compounds that are currently or could potentially be used in herbal smoking mixtures. This approach provides accelerated analysis and results that distinguish between structural analogs within several classes of cannabinoid compounds, including positional isomers. The analytical results confirm the continued manufacture and distribution of herbal materials with synthetic cannabinoids and provide insight into the manipulation of these products to avoid legal constraints and prosecution.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22582264      PMCID: PMC3611872          DOI: 10.1093/jat/bks025

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  10 in total

1.  How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case study.

Authors:  Paul Griffiths; Roumen Sedefov; Ana Gallegos; Dominique Lopez
Journal:  Addiction       Date:  2010-06       Impact factor: 6.526

2.  Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products.

Authors:  Simon Hudson; John Ramsey; Les King; Sarah Timbers; Steve Maynard; Paul I Dargan; David M Wood
Journal:  J Anal Toxicol       Date:  2010-06       Impact factor: 3.367

Review 3.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 4.  Latest advances in cannabinoid receptor agonists.

Authors:  Ganesh A Thakur; Ritesh Tichkule; Shama Bajaj; Alexandros Makriyannis
Journal:  Expert Opin Ther Pat       Date:  2009-12       Impact factor: 6.674

5.  The emergence and analysis of synthetic cannabinoids.

Authors:  Simon Hudson; John Ramsey
Journal:  Drug Test Anal       Date:  2011-02-21       Impact factor: 3.345

6.  The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'.

Authors:  Paul I Dargan; Simon Hudson; John Ramsey; David M Wood
Journal:  Int J Drug Policy       Date:  2011-04-08

7.  Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.

Authors:  Nahoko Uchiyama; Ruri Kikura-Hanajiri; Jun Ogata; Yukihiro Goda
Journal:  Forensic Sci Int       Date:  2010-05-20       Impact factor: 2.395

8.  Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.

Authors:  Sebastian Dresen; Nerea Ferreirós; Michael Pütz; Folker Westphal; Ralf Zimmermann; Volker Auwärter
Journal:  J Mass Spectrom       Date:  2010-10       Impact factor: 1.982

Review 9.  Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development.

Authors:  R G Pertwee
Journal:  Expert Opin Investig Drugs       Date:  2000-07       Impact factor: 6.206

Review 10.  Emerging strategies for exploiting cannabinoid receptor agonists as medicines.

Authors:  Roger G Pertwee
Journal:  Br J Pharmacol       Date:  2009-02       Impact factor: 8.739

  10 in total
  9 in total

1.  Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs.

Authors:  Megan Grabenauer; Wojciech L Krol; Jenny L Wiley; Brian F Thomas
Journal:  Anal Chem       Date:  2012-06-20       Impact factor: 6.986

2.  Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.

Authors:  Jenny L Wiley; Julie A Marusich; Timothy W Lefever; Megan Grabenauer; Katherine N Moore; Brian F Thomas
Journal:  Neuropharmacology       Date:  2013-08-02       Impact factor: 5.250

3.  Rapid analysis of synthetic cannabinoids using a miniature mass spectrometer with ambient ionization capability.

Authors:  Qiang Ma; Hua Bai; Wentao Li; Chao Wang; R Graham Cooks; Zheng Ouyang
Journal:  Talanta       Date:  2015-04-24       Impact factor: 6.057

4.  Identification of Eight Synthetic Cannabinoids, Including 5F-AKB48 in Seized Herbal Products Using DART-TOF-MS and LC-QTOF-MS as Nontargeted Screening Methods.

Authors:  Katherine N Moore; Demetra Garvin; Brian F Thomas; Megan Grabenauer
Journal:  J Forensic Sci       Date:  2017-06-09       Impact factor: 1.832

Review 5.  Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids.

Authors:  Jenny L Wiley; Julie A Marusich; John W Huffman
Journal:  Life Sci       Date:  2013-09-23       Impact factor: 5.037

Review 6.  Analytical surveillance of emerging drugs of abuse and drug formulations.

Authors:  Brian F Thomas; Gerald T Pollard; Megan Grabenauer
Journal:  Life Sci       Date:  2012-11-12       Impact factor: 5.037

7.  Hijacking of Basic Research: The Case of Synthetic Cannabinoids.

Authors:  Jenny L Wiley; Julie A Marusich; John W Huffman; Robert L Balster; Brian F Thomas
Journal:  Methods Rep RTI Press       Date:  2011-11

8.  Comprehensive review of the detection methods for synthetic cannabinoids and cathinones.

Authors:  Akira Namera; Maho Kawamura; Akihiro Nakamoto; Takeshi Saito; Masataka Nagao
Journal:  Forensic Toxicol       Date:  2015-03-06       Impact factor: 4.096

Review 9.  Emerging drugs of abuse: current perspectives on synthetic cannabinoids.

Authors:  Danièle Debruyne; Reynald Le Boisselier
Journal:  Subst Abuse Rehabil       Date:  2015-10-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.